Treatment decisions for patients with active multiple sclerosis

JAMA Neurol. 2015 Apr;72(4):387-9. doi: 10.1001/jamaneurol.2014.4494.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Interferon-beta / therapeutic use*
  • Male
  • Multiple Sclerosis / drug therapy*
  • Propylene Glycols / therapeutic use*
  • Sphingosine / analogs & derivatives*

Substances

  • Immunologic Factors
  • Immunosuppressive Agents
  • Propylene Glycols
  • Interferon-beta
  • Sphingosine